YOLARX is world-renown for its scientific excellence in pharmacoepidemiology, pharmacovigilance, and therapeutic risk management.  Since its founding in 2006, YOLARX has developed and integrated an unique approach as it spans the product life-cycle following a roadmap which corresponds to the changing environment of drug regulation and reimbursement. Our goal is to provide expertise and research of the highest methodological standards that evaluate the benefits and risks of medicines in the real-world, for a global client base. Therapeutic areas in which YOLARX has worked include neuro-psychiatry, cardiovascular and metabolic disease, infectious disease, hematology/oncology, immunology/inflammation, pain, ophthalmology, dermatology, pulmonary disease, vaccinology, rare disease and biosimilars, … To learn more about YOLARX Consultants, please visit: www.yolarx.com.